These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21107661)

  • 1. Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):179-204. PubMed ID: 21107661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifespan based indirect response models.
    Krzyzanski W; Perez Ruixo JJ
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):109-23. PubMed ID: 22212685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.
    Krzyzanski W; Perez-Ruixo JJ; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):349-77. PubMed ID: 18551354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic models of age-structured cell populations.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):573-89. PubMed ID: 26377617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population cell life span models for effects of drugs following indirect mechanisms of action.
    Perez-Ruixo JJ; Kimko HC; Chow AT; Piotrovsky V; Krzyzanski W; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):767-93. PubMed ID: 16328102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General relationship between transit compartments and lifespan models.
    Koch G; Schropp J
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):343-55. PubMed ID: 22729453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response.
    Freise KJ; Schmidt RL; Widness JA; Veng-Pedersen P
    J Pharmacokinet Pharmacodyn; 2008 Oct; 35(5):527-52. PubMed ID: 18937059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distributed transit compartments for arbitrary lifespan distributions in aging populations.
    Koch G; Schropp J
    J Theor Biol; 2015 Sep; 380():550-8. PubMed ID: 26100181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans.
    Krzyzanski W; Woo S; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2006 Apr; 33(2):125-66. PubMed ID: 16565883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.
    Sun YN; Jusko WJ
    J Pharm Sci; 1998 Jun; 87(6):732-7. PubMed ID: 9607951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
    Ait-Oudhia S; Scherrmann JM; Krzyzanski W
    J Pharmacol Exp Ther; 2010 Sep; 334(3):897-910. PubMed ID: 20501635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):57-78. PubMed ID: 11253614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transit and lifespan in neutrophil production: implications for drug intervention.
    Câmara De Souza D; Craig M; Cassidy T; Li J; Nekka F; Bélair J; Humphries AR
    J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):59-77. PubMed ID: 29236223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exact solutions and equi-dosing regimen regions for multi-dose pharmacokinetics models with transit compartments.
    Hof F; Bridge LJ
    J Pharmacokinet Pharmacodyn; 2021 Feb; 48(1):99-131. PubMed ID: 33040255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution and implementation of distributed lifespan models.
    Koch G; Schropp J
    J Pharmacokinet Pharmacodyn; 2013 Dec; 40(6):639-50. PubMed ID: 24178036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the dose-dependent time of peak effect in indirect response models.
    Majumdar A
    J Pharmacokinet Biopharm; 1998 Apr; 26(2):183-206. PubMed ID: 9795881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models for the red blood cell lifespan.
    Shrestha RP; Horowitz J; Hollot CV; Germain MJ; Widness JA; Mock DM; Veng-Pedersen P; Chait Y
    J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):259-74. PubMed ID: 27039311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.
    Savic RM; Jonker DM; Kerbusch T; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):711-26. PubMed ID: 17653836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeutics.
    Mo G; Gibbons F; Schroeder P; Krzyzanski W
    PLoS One; 2014; 9(10):e109747. PubMed ID: 25333487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
    Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM
    Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.